Objective: Patients with chronic kidney disease (CKD) are at higher risk for cardiovascular disease (CVD) than patients in the general population. One potentially modifiable risk factor for CVD in ...

The rise in kidney disease rates is a major concern for cardiovascular health around the world. Kidney disease increases heart disease risk, yet as many as 9 in 10 U.S. adults with chronic kidney ...

One big concern is that people with CKD are more likely to develop heart and blood vessel problems. This is known as ...

The overall rate of cardiovascular death or worsening heart failure, the trial's primary endpoint, was higher in the 60% of study participants who also had chronic kidney disease. However, tirzepatide ...

Benefits from vitamin D supplementation in kidney disease vary; routine testing is not recommended in otherwise healthy ...

The analysis supports the integration of sodium-glucose cotransporter 2 (SGLT2) inhibitors into treatment paradigms for ...

Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 ...

Rybelsus® reduced major adverse cardiovascular events by 14% vs placebo in adults with type 2 diabetes and cardiovascular and/or chronic kidney disease in the SOUL cardiovascular outcomes trial1.Data ...

chronic kidney disease and cardiovascular disease, including heart failure, atrial fibrillation, coronary heart disease, stroke and peripheral artery disease. It includes both people at risk for ...

This imbalance can cause bone weakness and increase the risk of heart disease and stroke. Chronic kidney disease makes it difficult for the kidneys to function properly, which can cause problems ...

The rise in kidney disease rates is a major concern for cardiovascular health around the world. Kidney disease increases heart disease risk, yet as many as 9 in 10 U.S. adults with chronic kidney ...